What is Johnson & Johnson's innovative medicine — total assets?

Johnson & Johnson (JNJ) reported innovative medicine — total assets of $78.12B in Q1 2026.

How has Johnson & Johnson's innovative medicine — total assets changed year-over-year?

Johnson & Johnson's innovative medicine — total assets increased by 33.0% year-over-year, from $58.73B to $78.12B.

What does innovative medicine — total assets mean?

This represents the total book value of assets specifically allocated to or utilized by the Innovative Medicine segment. It provides a view of the capital intensity and the scale of the resources dedicated to this business unit.

Johnson & Johnson JNJ Innovative Medicine — Total Assets

Other segment segments

MEDTECH

$86.18B+1.3%

General Corporate

$36.6B-26.6%

Similar metrics at other companies

DXPEInnovative Pumping Solutions — Total Assets

$516.9M—

GEFInnovative Closure Solutions — Total Assets

$220.9M—

EMRIntelligent Devices — Total Assets

$11.96B—

SPGIMarket Intelligence — Total Assets

$30.98B+6.7%

ASSTMedical Device — Total Assets

$17.63M—

CAHPharmaceutical and Specialty Solutions — Total Assets

$41.03B+14.8%

Other financials

Income statement

See full

Revenue$24.1B+9.9%

Gross profit$16.0B+9.8%

Operating income$6.3B+2.3%

Net income$5.2B-52.4%

EPS (diluted)$2.14-52.9%

Balance sheet

See full

Cash & equivalents$21.7B-43.6%

Total debt$55.0B+5.2%

Total equity$81.2B+3.9%

Total assets$200.89B+3.7%

Cash flow

See full

Operating cash flow$2.5B-39.8%

CapEx$1.0B+31.9%

Free cash flow$1.5B-56.6%

Valuation

See full

Market cap$623.71B+66.9%

Enterprise value$657.01B+61.9%

P/E29.6×+13.2×

P/S6.5×+2.3×

Profitability

See full

Gross margin67.8%-0.5pp

Operating margin26.4%+2.8pp

Net margin21.8%-2.6pp

FCF margin18.5%-4.3pp

Returns & leverage

See full

Return on equity26.4%-3.0pp

Debt / equity0.7×0.0×

Current ratio1×-0.2×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's innovative medicine — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Johnson & Johnson's innovative medicine — total assets?: Johnson & Johnson (JNJ) reported innovative medicine — total assets of $78.12B in Q1 2026.
How has Johnson & Johnson's innovative medicine — total assets changed year-over-year?: Johnson & Johnson's innovative medicine — total assets increased by 33.0% year-over-year, from $58.73B to $78.12B.
What does innovative medicine — total assets mean?: This represents the total book value of assets specifically allocated to or utilized by the Innovative Medicine segment. It provides a view of the capital intensity and the scale of the resources dedicated to this business unit.